![File:(R)-Bicalutamide levels with a single 5 to 80 mg oral dose of bicalutamide in men.png - Wikimedia Commons File:(R)-Bicalutamide levels with a single 5 to 80 mg oral dose of bicalutamide in men.png - Wikimedia Commons](https://upload.wikimedia.org/wikipedia/commons/4/43/%28R%29-Bicalutamide_levels_with_a_single_5_to_80_mg_oral_dose_of_bicalutamide_in_men.png)
File:(R)-Bicalutamide levels with a single 5 to 80 mg oral dose of bicalutamide in men.png - Wikimedia Commons
![Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration - TYRRElL - 2006 - BJU International - Wiley Online Library Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration - TYRRElL - 2006 - BJU International - Wiley Online Library](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/5dd0105e-9f12-4256-a4a4-101cbaf8d60f/bju_6275_f1.gif)
Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration - TYRRElL - 2006 - BJU International - Wiley Online Library
![Antineoplastic Agent Bicalutamide 50 mg Unit Dose, Film Coated Tablet Blister Pack 30 Tablets - Suprememed Antineoplastic Agent Bicalutamide 50 mg Unit Dose, Film Coated Tablet Blister Pack 30 Tablets - Suprememed](https://www.suprememed.com/wp-content/uploads/2022/02/antineoplasticagentbicalutamide50mgsan00781540964.jpg)
Antineoplastic Agent Bicalutamide 50 mg Unit Dose, Film Coated Tablet Blister Pack 30 Tablets - Suprememed
![Casodex 50mg - Prostate Cancer Drug Casodex 50 mg is a prostate cancer drug used in hormonal therapy to treat the same. It reduces production of androgen. - ppt download Casodex 50mg - Prostate Cancer Drug Casodex 50 mg is a prostate cancer drug used in hormonal therapy to treat the same. It reduces production of androgen. - ppt download](https://images.slideplayer.com/39/10840236/slides/slide_3.jpg)
Casodex 50mg - Prostate Cancer Drug Casodex 50 mg is a prostate cancer drug used in hormonal therapy to treat the same. It reduces production of androgen. - ppt download
![File:Bicalutamide levels after a single 10, 30, or 50 mg oral dose of bicalutamide in men.png - Wikimedia Commons File:Bicalutamide levels after a single 10, 30, or 50 mg oral dose of bicalutamide in men.png - Wikimedia Commons](https://upload.wikimedia.org/wikipedia/commons/thumb/c/cd/Bicalutamide_levels_after_a_single_10%2C_30%2C_or_50_mg_oral_dose_of_bicalutamide_in_men.png/1280px-Bicalutamide_levels_after_a_single_10%2C_30%2C_or_50_mg_oral_dose_of_bicalutamide_in_men.png)
File:Bicalutamide levels after a single 10, 30, or 50 mg oral dose of bicalutamide in men.png - Wikimedia Commons
![File:Mean plasma bicalutamide levels with 10 to 600 mg per day bicalutamide in men.png - Wikimedia Commons File:Mean plasma bicalutamide levels with 10 to 600 mg per day bicalutamide in men.png - Wikimedia Commons](https://upload.wikimedia.org/wikipedia/commons/5/5c/Mean_plasma_bicalutamide_levels_with_10_to_600_mg_per_day_bicalutamide_in_men.png)
File:Mean plasma bicalutamide levels with 10 to 600 mg per day bicalutamide in men.png - Wikimedia Commons
![These highlights do not include all the information needed to use BICALUTAMIDE TABLETS safely and effectively. See full prescribing information for BICALUTAMIDE TABLETS. BICALUTAMIDE tablets, for oral use Initial U.S. Approval: 1995 These highlights do not include all the information needed to use BICALUTAMIDE TABLETS safely and effectively. See full prescribing information for BICALUTAMIDE TABLETS. BICALUTAMIDE tablets, for oral use Initial U.S. Approval: 1995](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=bbed96d4-fcfd-4471-872b-2a0fafb48a4f-04.jpg&id=423658)
These highlights do not include all the information needed to use BICALUTAMIDE TABLETS safely and effectively. See full prescribing information for BICALUTAMIDE TABLETS. BICALUTAMIDE tablets, for oral use Initial U.S. Approval: 1995
![Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model | Scientific Reports Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-39533-3/MediaObjects/41598_2019_39533_Fig1_HTML.png)
Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model | Scientific Reports
![Radiotherapy Plus GnRH Analogue Versus High Dose Bicalutamide: A Case Control Study | Anticancer Research Radiotherapy Plus GnRH Analogue Versus High Dose Bicalutamide: A Case Control Study | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/39/11/6373/F1.large.jpg)
Radiotherapy Plus GnRH Analogue Versus High Dose Bicalutamide: A Case Control Study | Anticancer Research
![Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study - The Lancet Oncology Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/1e9acff9-0257-4a71-a70a-10e8ffcfcd0d/gr1.gif)
Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study - The Lancet Oncology
![Abiraterone acetate versus bicalutamide in combination with gonadotropin releasing hormone antagonist therapy for high risk metastatic hormone sensitive prostate cancer | Scientific Reports Abiraterone acetate versus bicalutamide in combination with gonadotropin releasing hormone antagonist therapy for high risk metastatic hormone sensitive prostate cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-89609-2/MediaObjects/41598_2021_89609_Fig1_HTML.png)
Abiraterone acetate versus bicalutamide in combination with gonadotropin releasing hormone antagonist therapy for high risk metastatic hormone sensitive prostate cancer | Scientific Reports
![Prostate Cancer Bicalutamide Tablets 50mg/150mg, For Clinical, Anti Cancer at best price in Gautam Budh Nagar Prostate Cancer Bicalutamide Tablets 50mg/150mg, For Clinical, Anti Cancer at best price in Gautam Budh Nagar](https://5.imimg.com/data5/AT/AF/MY-5907702/11-500x500.jpg)